AFLD 2013 FFC vs Respondent M57

Facts
The French Cycling Federation (French Fédération Française de Cyclisme, FFC) charges respondent M57 for a violation of the Anti-Doping Rules. During a cycle-cross race on November 18, 2012, a sample was taken for a doping test. The sample showed the presence of nikethamide and it's metabolite N-ethylnicotinamide and betamethasone which are prohibited substances on the World Anti-Doping Agency (WADA) prohibited list. Betamethanose is regarded as a specified substance.

History
The respondent had used medication to treat pain in his tibia, but he has no medical certificate for this. This medication is the cause of the positive test.

Decision
1. The sanction is a period of 6 months of ineligibility in which the athlete can't take part in competition or manifestations organized by the FFC.
2. The period of ineligibility will be reduced by the period allready served in voluntary suspension.
3. The present decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
30 May 2013
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S6. Stimulants
S9. Glucocorticosteroids
Substances
Betamethasone
Nikethamide
Medical terms
Physical injury
Treatment / self-medication
Document type
Pdf file
Date generated
28 January 2014
Date of last modification
25 September 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin